Advertisement

Cutaneous Blood Flow in Type 2 Diabetic Individuals After an Acute Bout of Maximal Exercise

  1. Sheri R. Colberg, PHD1,
  2. Henri K. Parson, PHD2,
  3. D. Robb Holton, MA1,
  4. Tanja Nunnold, MA1 and
  5. Aaron I. Vinik, MD, PHD2
  1. 1Old Dominion University, Norfolk, Virginia
  2. 2Strelitz Diabetes Institutes at Eastern Virginia Medical School, Norfolk, Virginia

    Abstract

    OBJECTIVE—We previously demonstrated a positive association between chronic aerobic exercise and dorsal foot skin blood flow during local heating in type 2 diabetic individuals. Thus, we hypothesized that a prior acute bout of maximal exercise would also have positive effects on postexercise blood flow.

    RESEARCH DESIGN AND METHODS—Subjects consisted of 32 individuals with type 2 diabetes and 26 nondiabetic control subjects further subdivided based on their physical activity status: diabetic exerciser (DE), diabetic sedentary (DS), control exerciser (CE), or control sedentary. Dorsal foot cutaneous blood flow was measured noninvasively by continuous laser-Doppler assessment at baseline and during local heating to 44°C before and after a maximal bout of cycle exercise. Interstitial nitric oxide (NO) levels were measured concurrently in the foot dorsum.

    RESULTS—Increases in blood flow and its responsiveness to local heating to 44°C were significantly lower in both diabetic groups compared with CE before maximal exercise, but perfusion responsiveness remained lower in DS subjects only after exercise (P < 0.05). Baseline skin blood flow was not different among groups preexercise, but it was significantly increased postexercise in DE subjects only. Interstitial NO levels were not significantly different at either time. At baseline, groups differed only in HbA1c, fasting serum glucose, HDL cholesterol, and insulin resistance (homeostasis model assessment method).

    CONCLUSIONS—All diabetic individuals exhibit a blunted responsiveness of cutaneous blood flow with local heating to 44°C before maximal exercise compared with active nondiabetic individuals, but after an exercise bout, it remains significantly blunted only in diabetic individuals who are sedentary. These findings occur independently of changes in interstitial NO levels.

    Footnotes

    • Address correspondence and reprint requests to Sheri Colberg PhD, ESPER Department, Old Dominion University, Norfolk, VA 23529. E-mail: scolberg{at}odu.edu.

      Received for publication 26 August 2002 and accepted in revised form 18 February 2003.

      A.I.V. has served as a consultant or speaker for Pfizer, Genetech, Merck, Eli Lilly, Athena, Bristol Myer Squibb, Knoll Pharamceuticals, GlaxoSmithKline Beecham, Boston Medical Technologies, Neurometrix, Guilford Pharmaceuticals, R.W. Johnson, Takeda, TEVA Pharmaceutical Industries, and Astra Zeneca. A.I.V. has received grant support from GMP Endotherapeutics, the American Diabetes Association, Eli Lilly, Parke-Davis, Astamedica, SmithKline Beecham, and R.W. Johnson.

      A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

    | Table of Contents
    Advertisement